Diarmuid Coughlan

Diarmuid Coughlan

Newcastle University

H-index: 15

Europe-United Kingdom

About Diarmuid Coughlan

Diarmuid Coughlan, With an exceptional h-index of 15 and a recent h-index of 13 (since 2020), a distinguished researcher at Newcastle University, specializes in the field of Health Technology Assessment, Health Economics, Epidemiology, Cancer Prevention and Care.

His recent articles reflect a diverse array of research interests and contributions to the field:

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

Repurposed Drugs in Childhood Cancers: A Scoping Review of Clinical Trials and Observational Studies

Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review …

Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation

Evaluating high-cost technologies–no need to throw the baby out with the bathwater

Time for consensus on “high-risk”–Sentinel lymph node biopsy for cutaneous squamous cell carcinoma: An international survey of skin cancer specialists and a literature update

Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review

Health Technology Assessment (HTA)

Diarmuid Coughlan Information

University

Position

___

Citations(all)

1122

Citations(since 2020)

891

Cited By

512

hIndex(all)

15

hIndex(since 2020)

13

i10Index(all)

20

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Diarmuid Coughlan Skills & Research Interests

Health Technology Assessment

Health Economics

Epidemiology

Cancer Prevention and Care

Top articles of Diarmuid Coughlan

Title

Journal

Author(s)

Publication Date

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

PharmacoEconomics

Diarmuid Coughlan

Oluwatomi Arisa

Katie Thomson

Ge Yu

Fiona Pearson

...

2023/10/5

Repurposed Drugs in Childhood Cancers: A Scoping Review of Clinical Trials and Observational Studies

Aina M Shaju

Diarmuid Coughlan

Ross Fairbairn

Sola Akinbolade

Katie Thomson

2023/7/3

Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review …

Frontiers in Oncology

Sara M Tolaney

Muralidhar Beeram

J Thaddeus Beck

Alison Conlin

E Claire Dees

...

2022/2/10

Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation

Maha F Althuwaibi

Cristina Fernandez-Garcia

Louise Hayes

Richard McNally

Diarmuid Coughlan

2023/6/26

Evaluating high-cost technologies–no need to throw the baby out with the bathwater

Gurdeep S Sagoo

Tomos Robinson

Diarmuid Coughlan

Nick Meader

Stephen Rice

...

2023/11/26

Time for consensus on “high-risk”–Sentinel lymph node biopsy for cutaneous squamous cell carcinoma: An international survey of skin cancer specialists and a literature update

Journal of Plastic, Reconstructive & Aesthetic Surgery

Bence C Baljer

Sarah R Hill

Diarmuid Coughlan

Luke Vale

Aidan M Rose

2023/1/1

Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review

Tafadzwa Patience Kunonga

RPW Kenny

Margaret Astin

Andrew Bryant

Vasileios Kontogiannis

...

2023/9/1

Health Technology Assessment (HTA)

Luke Vale

Diarmuid Coughlan

Michael Drinnan

2023/7/14

Implications for practice

Christopher I Price

Phil White

Joyce Balami

Nawaraj Bhattarai

Diarmuid Coughlan

...

2022/5

Combination therapies for COVID‐19: An overview of the clinical trials landscape

Sola Akinbolade

Diarmuid Coughlan

Ross Fairbairn

Glenn McConkey

Helen Powell

...

2022/4

Improving emergency treatment for patients with acute stroke: the PEARS research programme, including the PASTA cluster RCT

Christopher I Price

Phil White

Joyce Balami

Nawaraj Bhattarai

Diarmuid Coughlan

...

2022/1/1

Optimal Surveillance Strategies for Early-Stage Cutaneous Melanoma Post Primary Tumor Excision: An Economic Evaluation

MDM Policy & Practice

Vasileios Kontogiannis

Diarmuid Coughlan

Mehdi Javanbakht

Patience Kunonga

Fiona Beyer

...

2022/1

OP55 Classification System For Innovative Medicines In The Pipeline: New Or Repurposed?

International Journal of Technology Assessment in Health Care

Dapo Ogunbayo

Diarmuid Coughlan

Ross Fairbairn

Sola Akinbolade

2022/12

Low-dose computerised tomography screening for lung cancer in Singapore: Practical challenges of identifying participants.

Annals of the Academy of Medicine, Singapore

Bhumika Aggarwal

Diarmuid Coughlan

2022/10/1

Physical activity and the insurance industry

Diarmuid Coughlan

2021/8/1

Effects of primary biliary cholangitis on quality of life and health care costs in the United Kingdom

Clinical Gastroenterology and Hepatology

Stephen Rice

Viviana Albani

Dimitrios Minos

Gulnar Fattakhova

George F Mells

...

2021/4/1

Leisure time physical activity throughout adulthood is associated with lower medicare costs: evidence from the linked NIH-AARP diet and health study cohort

BMJ Open Sport & Exercise Medicine

Diarmuid Coughlan

Pedro F Saint-Maurice

Susan A Carlson

Janet Fulton

Charles E Matthews

2021/3/1

Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerations

Emergency Medicine Journal

Diarmuid Coughlan

Peter McMeekin

Darren Flynn

Gary A Ford

Hannah Lumley

...

2021/1/1

Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model

Luke Vale

Patience Kunonga

Diarmuid Coughlan

Vasileios Kontogiannis

Margaret Astin

...

2021/11

Using Best-Worst Scaling to Understand the Preferences of Stroke Survivors, their Relatives/Carers and the Public on Providing Stroke Thrombectomy Services in England

Darren Flynn

Hannah Lumley

Diarmuid Coughlan

David Burgess

Tomos Robinson

...

2020/5/20

See List of Professors in Diarmuid Coughlan University(Newcastle University)

Co-Authors

academic-engine